newsfilter
← Latest News
Business Wire·

Sierra Oncology to Present at B. Riley Securities Oncology Investor Conference

Sierra Oncology, Inc. (NASDAQ:SRRA), a late-stage biopharmaceutical company dedicated to delivering targeted therapies for rare cancers, today announced the company will participate in the 2022 B. Riley Securities Oncology Investor Conference being held